Granules India expects FDA nod for drug from Gagillapur facility by FY26 - Business News, Finance News, Share Market News - Market trendz

Post Top Ad

Monday, 30 December 2024

Granules India expects FDA nod for drug from Gagillapur facility by FY26


It had voluntarily paused production in September

Post Bottom Ad